ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2018 to Q3 2022

Type / Class
Equity / COM
Symbol
ETTX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$12,545,000 0
2022 Q2 5,701,341 $12,545,000 +$5,967,031 $2.20 26
2022 Q1 3,087,210 $5,773,000 -$528,999 $1.87 20
2021 Q4 3,305,549 $7,234,000 -$346,474 $2.19 23
2021 Q3 3,390,458 $11,323,000 +$199,693 $3.34 27
2021 Q2 3,330,590 $8,893,000 -$2,042,912 $2.67 21
2021 Q1 4,365,492 $9,342,000 -$436,505 $2.14 22
2020 Q4 4,519,210 $11,054,000 -$12,831,071 $2.47 24
2020 Q3 9,779,162 $19,859,000 +$4,715,993 $2.04 28
2020 Q2 7,413,896 $21,812,000 -$2,662,419 $2.96 19
2020 Q1 8,313,370 $21,764,000 -$685,797 $2.64 18
2019 Q4 8,569,919 $42,519,000 +$2,461,309 $4.97 16
2019 Q3 8,065,174 $48,010,000 -$2,747,097 $5.96 21
2019 Q2 8,533,766 $54,887,000 -$18,150 $6.45 19
2019 Q1 8,536,731 $57,524,000 -$195,007 $6.76 17
2018 Q4 8,579,830 $34,820,000 +$2,140,894 $4.07 18
2018 Q3 7,152,973 $77,558,000 +$77,558,000 $10.88 18